【24h】

Nanostructured Ceramic Coatings for Drug Delivery

机译:纳米结构陶瓷涂料用于药物递送

获取原文
获取外文期刊封面目录资料

摘要

Drug eluting stents (DES) have been successfully implemented in clinical practice in the treatment against coronary artery disease. Compared to the implantation of bare metal stents, restenosis rates decreased significantly after stenting of DES into coronary arteries [1, 2, 3]. This project aims at creating a novel, structured, ceramic drug delivering coating for stent implants. In the following, the preparation of a titanium dioxide (TiO_2) film with macroporous drug reservoirs in a mesoporbus bulk ceramic is shown. The film is predominantly composed of anatase. The broad pore size distribution has a median pore width below 100nm. The open porosity of the mesoporous bulk, which is greater than 50%, and the embedded macropores were successfully loaded with Paclitaxel (PTX). The quantity of drug loaded reaches values up to 1.2μg/mm~2. The continuous release of the agent into water extends over 1 month. The biocompatibility of the non PTX-loaded, nanostructured coating tested with primary bovine endothelial cells shows good results regarding the number of living cells, the cell vitality and morphology.
机译:药物洗脱支架(DES)已在临床实践中成功实施治疗冠状动脉疾病。与裸金属支架的植入相比,在冠状动脉的止损后,再狭窄率显着下降[1,2,3]。该项目旨在为支架植入物创建一种新颖,结构化的陶瓷药物,用于支架植入物。在下文中,二氧化钛(的TiO_2)膜的大孔药物容器在mesoporbus制备整块陶瓷中示出。该薄膜主要由锐钛矿组成。宽孔径分布的孔径低于100nm。中孔体积的开放孔隙率大于50%,并用紫杉醇(PTX)成功地装载了嵌入的大孔。负载的药物量达到高达1.2μg/ mm〜2的值。试剂进入水的连续释放超过1个月。用原发性牛内皮细胞测试的非PTX负载的纳米结构涂层的生物相容性显示出对活细胞的数量,细胞生命力和形态学的良好结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号